Spotting the BAP1 Gene Mutation in Mesothelioma Patients
| | | |

Spotting the BAP1 Gene Mutation in Mesothelioma Patients

New guidelines may make it easier to tell which mesothelioma patients contracted the disease because of a BAP1 gene mutation. The knowledge could have an impact on mesothelioma treatment planning. BAP1 stands for BRCA associated protein-1. People who have an inherited BAP1 gene mutation face a higher risk for several conditions, including malignant mesothelioma.  Very few mesothelioma patients have the mutation and gene testing is not routine. So researchers at a top US cancer center have developed a set of screening criteria. The criteria may help predict which mesothelioma patients could benefit from genetic testing. Testing for the Altered Gene Mesothelioma is just one of the conditions associated with the inherited BAP1 gene mutation. People with this condition are also…

BAP1 Mutation Unlikely to Trigger Sporadic Mesothelioma
| | | | | | |

BAP1 Mutation Unlikely to Trigger Sporadic Mesothelioma

But researchers at the Clinic of Oncology at the University Hospital of Zurich and University Hospitals in Leuven, Belgium say they have evidence to show that BAP1 mutations account for only a tiny percentage of sporadic mesothelioma cases. Mesothelioma is normally associated with exposure to asbestos dust and previous studies have found that people with the BAP1 mutation are more susceptible to cancer-causing effects of asbestos. Twenty-three percent of mesothelioma tumor specimens have been found to have a mutated BAP1 gene. But some cases of mesothelioma appear to arise “sporadically”, with no history of asbestos exposure.  Researchers around the world have long been trying to pinpoint the reasons these sporadic mesothelioma cases develop in an effort to prevent and/or treat…